ASGITFSNSGMHW(Val-13C5,15N)R (TFA)

CAT:
804-HY-159046S
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
ASGITFSNSGMHW(Val-13C5,15N)R (TFA) - image 1

ASGITFSNSGMHW(Val-13C5,15N)R (TFA)

  • UNSPSC Description:

    ASGITFSNSGMHW(Val-13C5,15N)R TFA is an isotope of ASGITFSNSGMHWVR TFA labeled with 13C and 15N[1].
  • Target Antigen:

    Isotope-Labeled Compounds
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Others
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/asgitfsnsgmhw-val-13c5-15n-r-tfa.html
  • Smiles:

    O=C(N[C@@H](CO)C(NCC(N[C@@H]([C@@H](C)CC)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(NCC(N[C@@H](CCSC)C(N[C@@H](CC2=CNC=N2)C(N[C@@H](CC3=CNC4=CC=CC=C34)C([15NH][13C@@H]([13CH]([13CH3])[13CH3])[13C](N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N
  • Molecular Weight:

    1655.78 (free acid)
  • References & Citations:

    [1]Russak E M, et al. Impact of deuterium substitution on the pharmacokinetics of pharmaceuticals[J]. Annals of Pharmacotherapy, 2019, 53(2): 211-216.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported